Cannabis biotech Anandia Labs raises C$13.4 million in private placement
Vancouver-based cannabis biotech Anandia Laboratories announced it raised CAD$63 million through a private placement financing of 13.4 million common shares. Green Acre Capital and York Plains Investment Corp were lead investors.
Anandia Labs is a cannabis analytics, testing and genetics company. It has one of 33 Health Canada-issued dealer’s licenses enabling it to cultivate, extract, test, import and export cannabis. It provides services including potency, pesticides, microbes and terpenes to licensed producers and patients, and helps customers analyze their test results and resolve any non-conformities.
Anandia also uses genomics and plant breeding technologies to develop products, and has built a significant collection of cannabis germplasm.
Dr. Jonathan Page, Anandia Labs’ co-founder and CEO stated, “…We anticipate significant growth over the next few years as we expand our licensed R&D and product development facilities and testing capabilities to meet the growing needs of the Canadian and global cannabis industry…”
“A partnership with Anandia was important to us given they are the gold standard in quality assurance testing for licensed producers. We are very excited to see …their creative work in genetics, tissue culture, extractions and processing,” added Tyler Stuart, Managing Director of Green Acre Capital.
Anandia Labs has approximately a 20% market share of the analytics and genetics testing market. It operates out of a 5,400 sf facility in Vancouver, with plans to construct a 40,000 sf cannabis innovation center in British Columbia in 2018.
The Financing will fund the land purchase and construction of the initial phase of Anandia Labs’ Cannabis Innovation Centre.
Source Anandia Labs press release
About Cannin.com: Your Marijuana Stocks Resource
Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.
Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?
Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp Stocks to Buy